U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776977) titled 'Bedtime Device Restriction and Desmopressin in PMNE.' on Aug. 18.
Brief Summary: This randomized controlled trial will evaluate whether restricting bedtime digital-device use improves the response to desmopressin in children with primary monosymptomatic nocturnal enuresis. Participants will receive desmopressin for 8 weeks and will be assigned to either bedtime device restriction or usual screen habits.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Primary Monosymptomatic Nocturnal Enuresis
Intervention:
DRUG: Desmopressin
Oral desmopressin administered at bedtime for 8 weeks for treatment of primary mono...